Humanized antibodies that recognize alpha-synuclein
US8609820B2 · kind B2 · utility
24Cited by
11References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 26, 2012 |
| Grant date | Dec 17, 2013 |
| Priority date | — |
| Expiry date | Oct 26, 2032 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/2835
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present application discloses humanized 9E4 antibodies. The antibodies bind to human alpha synuclein and can be used for immunotherapy of Lewy body disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.